Skip to Main Content

Author Details

Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
2004
224
69
PMIDPaper TitleJournal TitlePublished Year
37611810The Auto-Lindberg Project: Standardized Target Nomenclature in Radiation Oncology Enables Real-World Data Extraction From Radiation Treatment Plans.Int J Radiat Oncol Biol Phys2024
37611810The Auto-Lindberg Project: Standardized Target Nomenclature in Radiation Oncology Enables Real-World Data Extraction From Radiation Treatment Plans.Int J Radiat Oncol Biol Phys2024
36726714The impact of violating the independence assumption in meta-analysis on biomarker discovery.Front Genet2023
36409930CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer.Cancer Immunol Res2023
37847590Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.Cell Rep2023
37669321Spatial transformation of multi-omics data unlocks novel insights into cancer biology.Elife2023
37745558Decoding biological age from face photographs using deep learning.medRxiv2023
37572657A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.Med2023
37566240Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.Clin Cancer Res2023
37873411Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease.medRxiv2023
37397861Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics.Cancer Res Commun2023
36948414Effect of Radiation Therapy Quality Assurance on Nasopharyngeal Carcinoma: Usage of a Novel, Web-Based Quality Assurance Application.Pract Radiat Oncol2023
36688707Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis.J Natl Cancer Inst2023
36726714The impact of violating the independence assumption in meta-analysis on biomarker discovery.Front Genet2023
37543610Heterogeneity in leukemia cells that escape drug-induced senescence-like state.Cell Death Dis2023
37669321Spatial transformation of multi-omics data unlocks novel insights into cancer biology.Elife2023
37847590Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.Cell Rep2023
37745558Decoding biological age from face photographs using deep learning.medRxiv2023
37543610Heterogeneity in leukemia cells that escape drug-induced senescence-like state.Cell Death Dis2023
37873411Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease.medRxiv2023
37572657A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.Med2023
37566240Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.Clin Cancer Res2023
36948414Effect of Radiation Therapy Quality Assurance on Nasopharyngeal Carcinoma: Usage of a Novel, Web-Based Quality Assurance Application.Pract Radiat Oncol2023
37397861Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics.Cancer Res Commun2023
36409930CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer.Cancer Immunol Res2023
36688707Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis.J Natl Cancer Inst2023
34655289Artificial intelligence for drug response prediction in disease models.Brief Bioinform2022
35652221REFLECTions on Combination Therapies Empowered by Data Sharing.Cancer Discov2022
35585485Evaluation of statistical approaches for association testing in noisy drug screening data.BMC Bioinformatics2022
35578032PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.Nat Chem Biol2022
36280687Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.Nat Commun2022
36070391The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER<sup>+</sup> breast cancer with mitotic aberrations.Sci Adv2022
36055464Leveraging big data of immune checkpoint blockade response identifies novel potential targets.Ann Oncol2022
35536872Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity.Cancer Res2022
35260776Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma.Commun Biol2022
35041461Signaling by the tyrosine kinase Yes promotes liver cancer development.Sci Signal2022
34911733Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.Cancer Discov2022
34850112PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis.Nucleic Acids Res2022
34655289Artificial intelligence for drug response prediction in disease models.Brief Bioinform2022
35304464Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids.Nat Commun2022
35585485Evaluation of statistical approaches for association testing in noisy drug screening data.BMC Bioinformatics2022
35652221REFLECTions on Combination Therapies Empowered by Data Sharing.Cancer Discov2022
35578032PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.Nat Chem Biol2022
35536872Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity.Cancer Res2022
36280687Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.Nat Commun2022
36070391The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER<sup>+</sup> breast cancer with mitotic aberrations.Sci Adv2022
36055464Leveraging big data of immune checkpoint blockade response identifies novel potential targets.Ann Oncol2022
35041461Signaling by the tyrosine kinase Yes promotes liver cancer development.Sci Signal2022
34911733Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.Cancer Discov2022
34850112PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis.Nucleic Acids Res2022
  • 1 - 50 of 448

Recommended Authors

Mehmet Eren Ahsen
Gies College of Business, University of Illinois at Urbana-Champaign.
Career Start Year 2015
Number of shared co-authors 1
Matthew Ung
Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth
Career Start Year 2013
Number of shared co-authors 2
Kiley Graim
University of Florida.
Career Start Year 2013
Number of shared co-authors 4
Elana J Fertig
Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 11
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 6
Stephen R Piccolo
Brigham Young University
Career Start Year 2008
Number of shared co-authors 7
Fathi Elloumi
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 2007
Number of shared co-authors 13
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 4
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 12
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 4
Justin Guinney
University of Washington
Career Start Year 2006
Number of shared co-authors 14
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 16
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 11
Chao Cheng
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 8
Gabriela Alexe
Dana-Farber Cancer Institute
Career Start Year 2004
Number of shared co-authors 4
Adam A Margolin
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 12
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 2
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 7
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 14
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2003
Number of shared co-authors 7
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 25
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 34
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 3
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 15
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 4
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 9
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 3
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 8
Pablo Tamayo
University of California San Diego
Career Start Year 1988
Number of shared co-authors 15

Collaborators

Christos Sotiriou
Co-authored papers 38
John Quackenbush
Harvard T. H. Chan School of Public Health
Co-authored papers 27
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Co-authored papers 23
David W Cescon
Princess Margaret Cancer Centre
Co-authored papers 18
Zhaleh Safikhani
Princess Margaret Cancer Center, University Health Network
Co-authored papers 18
Hugo J W L Aerts
Harvard Medical School
Co-authored papers 17
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers 16
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Co-authored papers 15
Deena M A Gendoo
Institute of Cancer and Genomic Sciences, University of Birmingham
Co-authored papers 15
Arvind Singh Mer
University of Ottawa
Co-authored papers 14
Anna Goldenberg
SickKids Research Institute
Co-authored papers 12
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Co-authored papers 12
Seyed Ali Madani Tonekaboni
Princess Margaret Cancer Research Centre
Co-authored papers 10
Frank Emmert-Streib
Tampere University
Co-authored papers 10
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 10
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 10
Levi Waldron
City University of New York School of Public Health
Co-authored papers 9
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 8
William F Symmans
Co-authored papers 8
Mauro Delorenzi
Co-authored papers 7
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Lajos Pusztai
Co-authored papers 7
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 6
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Co-authored papers 6
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 6
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 5
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 5
Linda Z Penn
University of Toronto
Co-authored papers 5
Release 1.2